Ozmosi | Nifuratel Drug Profile

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Wangao Pharmaceutical
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial	Phase	Trial Status	Disease	Primary Completion Date	Latest Trial Update Date	Data Updated
CTR20243128	N/A	Completed	Candidiasis, Vulvovaginal	2025-05-23	2025-06-29	Primary Completion Date\|Study Completion Date\|Treatments\|Trial Status
CTR20232169	N/A	Completed	Trichomonas Infections	2024-06-02	2025-04-29	Patient Enrollment\|Primary Completion Date\|Start Date\|Study Completion Date\|Treatments\|Trial Status
CTR20232737	N/A	Recruiting	Trichomonas Infections	None	2025-04-29	Patient Enrollment\|Start Date\|Treatments\|Trial Status
CTR20244417	N/A	Not yet recruiting	Candidiasis, Vulvovaginal	None	2025-04-29	Patient Enrollment\|Treatments\|Trial Status

Recent News Events

Date	Type	Title
03/27/2024	PubMed	Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and Combination Therapy.
09/21/2023	PubMed	Nifuratel reduces Salmonella survival in macrophages by extracellular and intracellular antibacterial activity.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions

Nifuratel

Alternative Names: nifuratel Clinical Status: Inactive Latest Update: 2024-03-27 Latest Update Note: PubMed Publication